A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Secondary Hypogonadism at Patients Hormonally Treated for Prostatic Carcinoma from a Cardiologist Perspective
2019
Annals of Urology & Nephrology
In the cardiologist's care are often patients treated for erectile dysfunction or prostatic cancer and, vice versa, in the urologist or andrologist´s care patients treated for hypertension, arrhythmias and coronary heart disease. There is needed to respect mutually influences and take them in account at the diagnostic and therapeutic indications. Secondary hypogonadism at patients hormonally treated for prostatic carcinoma leads to loss of both positive testosterone effects on cardiovascular
doi:10.33552/aun.2019.01.000504
fatcat:kf4ekhi2mnd2vlkwkdbr5jqbuq